Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem)

Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem) is a pioneering organization founded in 2009 and headquartered in India. It is focused on thematic interdisciplinary research aimed at addressing significant questions in human biology through stem cell science. The organization's research efforts include investigating genetic mechanisms of potency, differentiation, and proliferation in human pluripotent cells, studying clinical manifestations of diseases that can potentially be treated by stem cells, utilizing model organisms such as Planaria and Hydra to address fundamental questions in regenerative biology, and developing platforms to interrogate signaling pathways with new chemical entities. Additionally, it works on developing tools to better understand the biology driving stem cells and eventually treat disease states. The research at DBT-inStem is carried out by groups working on tightly-knit themes, crossing boundaries, and developing new approaches to address questions larger than the expertise of individual researchers. The organization operates in the Biotechnology, Education, and Health Care industries, showcasing its potential for significant impact in various sectors. While specific investment details are currently unavailable, the work and focus of DBT-inStem position it as a promising player in the field of stem cell research and regenerative medicine, with potential attractiveness to investors seeking opportunities in cutting-edge biotechnological advances.